rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0027686,
umls-concept:C0042382,
umls-concept:C0078058,
umls-concept:C0085177,
umls-concept:C0185117,
umls-concept:C0205307,
umls-concept:C0851285,
umls-concept:C1256770,
umls-concept:C1412824,
umls-concept:C1514873,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C2911684
|
pubmed:issue |
11
|
pubmed:dateCreated |
2006-10-25
|
pubmed:abstractText |
The Zfp36l1 gene encodes a zinc finger-containing mRNA binding protein implicated in the posttranscriptional control of gene expression. Mouse embryos homozygous for a targeted mutation in the Zfp36l1 locus died mid-gestation and exhibited extraembryonic and intraembryonic vascular abnormalities and heart defects. In the developing placenta, there was a failure of the extraembryonic mesoderm to invaginate the trophoblast layer. The phenotype was associated with an elevated expression of vascular endothelial growth factor (VEGF)-A in the embryos and in embryonic fibroblasts cultured under conditions of both normoxia and hypoxia. VEGF-A overproduction by embryonic fibroblasts was not a consequence of changes in Vegf-a mRNA stability; instead, we observed enhanced association with polyribosomes, suggesting Zfp36l1 influences translational regulation. These data implicate Zfp36l1as a negative regulator of Vegf-a gene activity during development.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1058-8388
|
pubmed:author |
|
pubmed:copyrightInfo |
(c) 2006 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
235
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3144-55
|
pubmed:meshHeading |
pubmed-meshheading:17013884-Animals,
pubmed-meshheading:17013884-Gene Expression Regulation, Developmental,
pubmed-meshheading:17013884-Mice,
pubmed-meshheading:17013884-Mice, Mutant Strains,
pubmed-meshheading:17013884-Mutation,
pubmed-meshheading:17013884-Neovascularization, Physiologic,
pubmed-meshheading:17013884-Nuclear Proteins,
pubmed-meshheading:17013884-Polyribosomes,
pubmed-meshheading:17013884-RNA, Messenger,
pubmed-meshheading:17013884-RNA Stability,
pubmed-meshheading:17013884-RNA-Binding Proteins,
pubmed-meshheading:17013884-Transcription, Genetic,
pubmed-meshheading:17013884-Vascular Endothelial Growth Factor A
|
pubmed:year |
2006
|
pubmed:articleTitle |
The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression.
|
pubmed:affiliation |
Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Babraham, Cambridge, United Kingdom. sarah-e.bell@bbsrc.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|